bromopyruvate has been researched along with Kahler Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, F; Ikeda, S; Kitadate, A; Matsuda, Y; Tagawa, H; Takahashi, N | 1 |
| Casal, M; Ko, YH; Niedźwiecka, K; Pedersen, PL; Ułaszewski, S | 1 |
| Augustyniak, D; Bartkowiak, A; Goffeau, A; Gonchar, M; Ko, YH; Lis, P; Majkowska-Skrobek, G; Pedersen, PL; Ułaszewski, S | 1 |
| Augustyniak, D; Cal-Bąkowska, M; Dyląg, M; Goffeau, A; Ko, YH; Majkowska-Skrobek, G; Niedźwiecka, K; Pedersen, PL; Ułaszewski, S | 1 |
| Dyląg, M; Goffeau, A; Ko, YH; Lis, P; Niedźwiecka, K; Pedersen, PL; Ułaszewski, S | 1 |
| Abe, M; Amou, H; Fujii, S; Harada, T; Kagawa, K; Matsumoto, T; Miki, H; Nakamura, S; Nakano, A; Oda, A; Ozaki, S; Takeuchi, K | 1 |
1 review(s) available for bromopyruvate and Kahler Disease
| Article | Year |
|---|---|
The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate.
Topics: Antineoplastic Agents; Energy Metabolism; Glycolysis; Hexokinase; Humans; Liver Neoplasms; Mitochondria; Multiple Myeloma; Oxidative Phosphorylation; Pyruvates | 2016 |
5 other study(ies) available for bromopyruvate and Kahler Disease
| Article | Year |
|---|---|
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma.
Topics: Animals; Apoptosis; Autophagy; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glycolysis; Hexokinase; Humans; Hypoxia; Mice; Multiple Myeloma; Pyruvates; Stress, Physiological; Xenograft Model Antitumor Assays | 2020 |
3-Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor André Goffeau.
Topics: Animals; Antineoplastic Agents; Apoptosis; Disease Models, Animal; Fungi; Glycolysis; Hexokinase; Humans; Melanoma; Mitochondria; Multiple Myeloma; Neoplasms; Pyruvates; Pyruvic Acid | 2019 |
Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Benzamides; Buthionine Sulfoximine; Cell Survival; Glutathione; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Lactic Acid; Monocarboxylic Acid Transporters; Multiple Myeloma; Piperazines; Pyrimidines; Pyruvates; Symporters; Tumor Cells, Cultured | 2014 |
Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma.
Topics: Cells, Cultured; Enzyme Inhibitors; Glutathione; Humans; Infections; Multiple Myeloma; Mycoses; Prototheca; Pyruvates; Research Design | 2016 |
Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate.
Topics: Adenosine Triphosphate; Analysis of Variance; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hexokinase; Humans; Immunohistochemistry; Multiple Myeloma; Pyruvates; Real-Time Polymerase Chain Reaction | 2012 |